3Holroyd S,Currie L,Wooten GF.Prospective study of hallucinations and delusions in Parkinson's disease[J].J of Neurol,Neurosurg and Psychiatry,2001,70(6):734-738.
4Melamed E,Friedberg G,Zoldan J.Psychosis impacton the patients and family[J].Neurol,1999,52(Supp13):14-16.
5Turjanski N,Lloyd GG.Psychiatric sideeffects of medications:recent developments[J].Adv in Psychiatr Treat,2005,11(1):58-70.
8Wolters EC.Dopaminomimetic psychosis in Parkinson's disease patients[J].Neurol,1999,52(Supp13):10-13.
9Fernandez HH,Trieschmann ME,Burke MA,et al.Longterm outcome of quetiapine use for psychosis among Parkinsonian patients[J].Move Dis,2003,18(5):510-514.
10Tolosa E.Advances in the pharmacological management of Parkin-son disease[J].J of Neural Transmission,2003,Suppl(64):65-78.
4Ceravolo R,Frosini D,Rossi C,et al.Spectrum of addictions in Parkinson’s disease:from dopamine dysregulation syndrome to impulse control disorders[J].J Neurol,2010,257(Suppl2):276.
